KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash & Current Investments (2020 - 2025)

Oscar Health (OSCR) has disclosed Cash & Current Investments for 6 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 85.47% year-over-year to $4.0 billion, compared with a TTM value of $4.0 billion through Dec 2025, up 85.47%, and an annual FY2025 reading of $4.0 billion, up 85.47% over the prior year.
  • Cash & Current Investments was $4.0 billion for Q4 2025 at Oscar Health, up from $3.0 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $4.0 billion in Q4 2025 and bottomed at $1.7 billion in Q3 2021.
  • Average Cash & Current Investments over 5 years is $2.8 billion, with a median of $2.8 billion recorded in 2022.
  • The sharpest move saw Cash & Current Investments skyrocketed 451.2% in 2021, then tumbled 30.04% in 2024.
  • Year by year, Cash & Current Investments stood at $1.7 billion in 2021, then skyrocketed by 74.79% to $3.0 billion in 2022, then fell by 13.39% to $2.6 billion in 2023, then fell by 15.96% to $2.2 billion in 2024, then surged by 85.47% to $4.0 billion in 2025.
  • Business Quant data shows Cash & Current Investments for OSCR at $4.0 billion in Q4 2025, $3.0 billion in Q3 2025, and $3.5 billion in Q2 2025.